Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerNPI Medicare & MedicaidStephen Soloway
    Ask Trek AI about this page

    Stephen Soloway — Billing Profile & Reimbursement Data

    NPI 1609997873 · Vineland, NJ · Rheumatology Physician

    Customize your policy alerts

    Sign up for Stephen Soloway — Billing Profile & Reimbursement Data policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Stephen Soloway is a rheumatology physician provider located in Vineland, New Jersey. This profile covers 52 Medicare and 0 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.

    Table of contents

    Progress1 / 9

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Provider details (source: NPPES NPI Registry)

    FieldValue
    Entity TypeIndividual
    OrganizationStephen Soloway
    Address2848 S Delsea Dr
    CityVineland
    StateNJ
    ZIP08360
    TaxonomyRheumatology Physician
    NPI EnumeratedApril 3, 2007

    Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)

    Payer SourceTotal Paid
    Medicare$2.7M
    Medicaid$0

    Key Findings

    This provider is effectively single‑payer in the dataset: lifetime Medicare revenue is $2.7M while Medicaid shows none on file, indicating no recorded Medicaid billing activity and a business footprint that is concentrated in Medicare fee‑for‑service. That payer concentration means performance and contracting discussions should be evaluated primarily against Medicare benchmarks.

    Revenue is highly concentrated in a small number of biologic drug codes: the precomputed top 3 Medicare codes account for 66.4% of the provider’s total Medicare revenue. Those top three codes are J1745 ($983K, 36.7% of Medicare revenue), J1602 ($522.8K, 19.5%), and J0490 ($274.8K, 10.2%), showing that a majority of dollars flow through a few infusion drugs.

    The CPT/HCPCS mix points to an infusion‑centric rheumatology practice that supplies high‑cost biologics and performs repeated IV administrations: high‑revenue pharmacy J‑codes (J1745, J1602, J0490, J9312) appear alongside chemo/infusion administration codes (96413, 96415, 96365, 96375). This pattern is consistent with an operation that delivers frequent in‑office or infusion‑center biologic therapy rather than a clinic focused solely on short outpatient E/M visits.

    Several individual codes demonstrate outsized national standing: J1745 ranks #2 of 1352 providers nationally (100th percentile; extreme outlier), and J1602 ranks #45 of 1041 (96th percentile; notably above typical national volume). These rankings indicate this provider is a national high‑volume administrator for certain infliximab and golimumab formulations and would be considered a dominant participant for those specific drugs.

    In addition to biologics, the practice bills substantial infusion administration time: 96413 (1K claims, $115.9K revenue) ranks #71 of 7514 (99th percentile; extreme outlier) and 96415 (1.2K claims, $28.9K revenue) ranks #6 of 4959 (100th percentile; extreme outlier). The presence and ranking of these add‑on infusion/chemotherapy administration codes corroborate sustained, hour‑long infusion sessions and repeated infusion throughput.

    Operational throughput is evident in high claim counts for multiple injectables and infusions: J1602 shows 52.3K claims, J1745 37.8K claims, J3111 17.9K claims, and J0897 11.8K claims. These claim volumes, combined with the revenue concentration, suggest the provider maintains a high‑volume infusion workflow and inventory pipeline for biologic agents.

    Ancillary services and lower‑acuity outpatient care are present but numerically modest: office E/M codes (99214, 99213, 99204, 99205) and preventive services (90662, 90671, G0008) appear at low volumes relative to infusion codes, while DXA (77080) and joint injections (20610, J7321) show routine, supporting procedural activity. This supports a model where infusion and drug administration are the primary revenue drivers and office visits and diagnostics play a secondary role.

    The provider has an established operational history, with NPI enumeration on 2007‑04‑03 (~19 years ago), which aligns with sustained high volumes reported for several biologic and infusion codes. Given the concentration of revenue in a few J‑codes and multiple “extreme outlier” rankings, this profile carries concentration risk for revenue sensitivity to drug pricing, supply, or contracting changes and should be flagged in payer/provider network or contract reviews.

    Medicare: Total Revenue Breakdown by CPT/HCPCS Code

    Medicare revenue breakdown by CPT/HCPCS procedure code.

    View: Bar Chart1 / 2

    Medicare: Complete Services Breakdown

    The CPT/HCPCS codes generating the most Medicare revenue for this provider.

    52 rows

    CPT/HCPCS CodeDescriptionClaimsAvg PaidRevenue
    J1745Injection, infliximab, excludes biosimilar, 10 mg37,810$30$983K
    J1602Injection, golimumab, 1 mg, for intravenous use52,280$10$522.8K
    J0490Injection, belimumab, 10 mg6,870$40$274.8K
    J9312Injection, rituximab, 10 mg3,960$60$249.6K
    J0897Injection, denosumab, 1 mg11,760$20$211.7K
    J3111Injection, romosozumab-aqqg, 1 mg17,850$10$142.8K
    96413Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…1,030$110$115.9K
    96415In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the…1,210$20$28.9K
    96365The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.510$60$28K
    J1439Injection, ferric carboxymaltose, 1 mg27,000$1$27K

    Showing 1–10 of 52

    Medicare: Competitive Analysis & Benchmarks

    How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 52 CPT/HCPCS codes.

    View: State1 / 2

    Full comparison — all codes billed, vs. state median

    52 rows

    CPT/HCPCS CodeRankProvider CountMedian ClaimsAvg PaidAverage Revenue
    J04902107,360$40$293K
    J93122103,960$60$242.7K
    J160224012,580$10$165.7K
    J17451303,670$30$131.9K
    J311163012,600$10$107.3K
    J0897293803,060$20$87.8K
    J1439477034,880$1$36.5K
    964132230190$110$26.6K
    992147,99013,640130$90$23.6K
    9921310,33214,090100$70$13.1K

    Showing 1–10 of 52

    Related Providers

    Other providers that share a Tax Identification Number (TIN) with Stephen Soloway, ranked by combined Medicare and Medicaid revenue.

    ProviderStateTaxonomyMedicare RevenueMedicaid Revenue
    Arthritis & Rheumatology Associates Of South Jersey PCNJRheumatology Physician$0$53.4M
    Matthew ArkebauerNJRheumatology Physician$499.8K$0

    Nearby Providers

    Other providers in the same ZIP code as Stephen Soloway, ranked by combined Medicare and Medicaid revenue.

    ProviderStateTaxonomyMedicare RevenueMedicaid Revenue
    Inspira Medical Centers, Inc.NJGeneral Acute Care Hospital$0$227M
    Elwyn New JerseyNJIntellectual and/or Developmental Disabilities Community Based Residential Treatment Facility$0$206.7M
    Winter EnterprisesNJOral and Maxillofacial Surgery (Dentist)$0$17M
    Comminity Programs Inc.NJAdult Day Care Clinic/Center$0$13.7M
    City Of Vineland Board Of EducationNJLocal Education Agency (LEA)$0$12.8M
    Pinnacle Treatment Centers Nj Iii LLCNJMethadone Clinic$264.3K$10.9M
    Excelcare Alliance, LLCNJFamily Medicine Physician$0$11M
    Confident Care CorpNJHome Health Agency$0$8.2M
    City Of VinelandNJAmbulance$798.1K$1.6M
    Barry ShapiroNJCardiovascular Disease Physician$2.2M$0

    Frequently Asked Questions

    References

    1. 1.Medicare Physician & Other Practitioner by Provider and Service. CMS.gov.Provider-level Medicare Part B utilization and payment data.
    2. 2.NPPES NPI Registry. CMS.gov.National Provider Identifier registry used for provider enumeration and taxonomy metadata.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

    Medicare Revenue by CPT/HCPCS Code
    Claims Volume vs. New Jersey Distribution
    Stephen Soloway — 8 of 25 codes billed far more than typical (above p95)
    p5–p95 (all providers)p25–p75MedianThis providerOutlier
    Rank Distribution — New Jersey